Skip to content
★ Sign in to follow
MK

Mary K. Moreland

Executive
Chairman & CEO
Insider activity · 24 months0 buys3 salesCumulative net flow
Total declarations
34
Company
1
▲ Purchases (0 ops.)
—
▼ Sales (10 ops.)
€917k

Latest filing published 06 Nov 2026 for Abbott Laboratories, €361k.

Filing timeline

BuySale
Mary K. Moreland

Insider track record

Disclosed buys
0
Disclosed sells
10
Signal history

Mary K. Moreland: trading record in brief

All filings by Mary K. Moreland on record concern Abbott Laboratories, in the capacity of chief executive. Between 1 August 2019 and 5 November 2026, the trades on record add up to 34 filings.

Every open-market trade on record is a sale: 10 sales worth €917k. Outside the open market, there are 23 share grants. In 2026 alone, the filings show no purchases and 2 sales.

The latest filing, published on 6 November 2026, reports an open-market sale of €361k in Abbott Laboratories. The median gap between a trade and its publication by SEC (Form 4) is 2 days. US insiders must file a Form 4 within two business days of a trade. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.

Companies and markets linked to Mary K. Moreland

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations34 total
  • ▼
    EXECUTIVE VICE PRESIDENTExecutivesAbbott Laboratories
    406,000 USD0SEC
    3,500 shares@ US$116.00Common shares without par valueSEC:0001783147-26-000013:0
  • ●
    EXECUTIVE VICE PRESIDENTExecutivesAbbott Laboratories
    501,695 USD12SEC
    5,314 shares@ US$94.410.0003% mcap11.6% of flowCommon shares without par valueSEC:0001783147-26-000009:0
  • ◆
    EXECUTIVE VICE PRESIDENTExecutivesAbbott Laboratories
    538,284 USD12SEC
    4,630 shares@ US$116.2612.3% of flowCommon shares without par valueSEC:0001783147-26-000007:0
  • ▼
    EXECUTIVE VICE PRESIDENTExecutivesAbbott Laboratories
    70,851 USD29SEC
    613 shares@ US$115.581.6% of flowCommon shares without par valueSEC:0001783147-26-000007:1
  • ◆
    EXECUTIVE VICE PRESIDENTExecutivesAbbott Laboratories
    0SEC
    13,951 shares0Common shares without par valueSEC:0001783147-26-000002:0
  • ◆
    EXECUTIVE VICE PRESIDENTExecutivesAbbott Laboratories
    760,600 USD13SEC
    5,598 shares@ US$135.8719.8% of flowCommon shares without par valueSEC:0001415889-25-006786:0
  • ▼
    EXECUTIVE VICE PRESIDENTExecutivesAbbott Laboratories
    109,292 USD29SEC
    791 shares@ US$138.172.8% of flowCommon shares without par valueSEC:0001415889-25-006786:1
  • ◆
    EXECUTIVE VICE PRESIDENTExecutivesAbbott Laboratories
    0SEC
    10,712 shares0Common shares without par valueSEC:0001415889-25-005897:0
  • ▼
    EXECUTIVE VICE PRESIDENTExecutivesAbbott Laboratories
    80,106 USD29SEC
    676 shares@ US$118.501.5% of flowCommon shares without par valueSEC:0001415889-24-006410:1
  • ◆
    EXECUTIVE VICE PRESIDENTExecutivesAbbott Laboratories
    703,733 USD13SEC
    5,862 shares@ US$120.0517.6% of flowCommon shares without par valueSEC:0001415889-24-006410:0
  • ◆
    EXECUTIVE VICE PRESIDENTExecutivesAbbott Laboratories
    0SEC
    10,574 shares0Common shares without par valueSEC:0001415889-24-005105:0
  • ▼
    EXECUTIVE VICE PRESIDENTExecutivesAbbott Laboratories
    72,252 USD29SEC
    717 shares@ US$100.771.4% of flowCommon shares without par valueSEC:0001415889-23-003912:1
  • ◆
    EXECUTIVE VICE PRESIDENTExecutivesAbbott Laboratories
    591,237 USD13SEC
    5,926 shares@ US$99.7715.1% of flowCommon shares without par valueSEC:0001415889-23-003912:0
  • ◆
    EXECUTIVE VICE PRESIDENTExecutivesAbbott Laboratories
    0SEC
    12,259 shares0Common shares without par valueSEC:0001415889-23-003057:0
  • ◆
    EXECUTIVE VICE PRESIDENTExecutivesAbbott Laboratories
    135,506 USD11SEC
    1,245 shares@ US$108.843.6% of flowCommon shares without par valueSEC:0001415889-22-008158:0
  • ◆
    EXECUTIVE VICE PRESIDENTExecutivesAbbott Laboratories
    503,350 USD12SEC
    4,112 shares@ US$122.4112.2% of flowCommon shares without par valueSEC:0001415889-22-002197:0
  • ◆
    EXECUTIVE VICE PRESIDENTExecutivesAbbott Laboratories
    92,614 USD11SEC
    793 shares@ US$116.791.7% of flowCommon shares without par valueSEC:0001415889-22-001742:1
  • ▼
    EXECUTIVE VICE PRESIDENTExecutivesAbbott Laboratories
    47,724 USD0SEC
    400 shares@ US$119.31Common shares without par valueSEC:0001415889-22-001742:2
  • ◆
    EXECUTIVE VICE PRESIDENTExecutivesAbbott Laboratories
    0SEC
    15,813 shares0Common shares without par valueSEC:0001415889-22-001742:0
  • ◆
    EXECUTIVE VICE PRESIDENTExecutivesAbbott Laboratories
    150,620 USD11SEC
    1,245 shares@ US$120.983.4% of flowCommon shares without par valueSEC:0001415889-21-003773:0
  • ◆
    EXECUTIVE VICE PRESIDENTExecutivesAbbott Laboratories
    257,263 USD11SEC
    2,116 shares@ US$121.584.6% of flowCommon shares without par valueSEC:0001415889-21-001210:0
  • ◆
    EXECUTIVE VICE PRESIDENTExecutivesAbbott Laboratories
    95,971 USD11SEC
    780 shares@ US$123.041.7% of flowCommon shares without par valueSEC:0001415889-21-000897:1
  • ▼
    EXECUTIVE VICE PRESIDENTExecutivesAbbott Laboratories
    48,736 USD29SEC
    400 shares@ US$121.840.9% of flowCommon shares without par valueSEC:0001415889-21-000897:2
  • ◆
    EXECUTIVE VICE PRESIDENTExecutivesAbbott Laboratories
    0SEC
    13,513 shares0Common shares without par valueSEC:0001415889-21-000897:0
  • ◆
    EXECUTIVE VICE PRESIDENTExecutivesAbbott Laboratories
    129,384 USD11SEC
    1,009 shares@ US$128.232.3% of flowCommon shares without par valueSEC:0001415889-21-000751:0

25 of 34 declarations